Wordt geladen...
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
Autologous hematopoietic stem cell transplantation (AHSCT) has been used in the treatment of highly active multiple sclerosis (MS) for over two decades. It has been demonstrated to be highly efficacious in relapsing–remitting (RR) MS patients failing to respond to disease-modifying drugs (DMDs). AHS...
Bewaard in:
| Gepubliceerd in: | Neurol Ther |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Healthcare
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7606396/ https://ncbi.nlm.nih.gov/pubmed/32548740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-020-00200-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|